Emerging Approaches of Transcatheter Valve Repair/Insertion

Table 3

Procedural and in-hospital results of patients submitted to trans-apical and trans-axillary TAVI Approach in our Institution.

	Trans-apical	Trans-axillary
Patients (𝑛)	15	15
Hospital stay (days), mean ± SD	15.8 ± 4.8	8.7 ± 1
Procedural success, 𝑛 (%)	13 (86.6)	14 (93.3)
Need for permanent pacemaker, 𝑛 (%)	3 (20)	1 (6.7)
Neurological events, 𝑛 (%)	1 (6.7)	1 (6.7)
Acute renal failure requiring CVVH, 𝑛 (%)	4 (26.6)	2 (13.3)
30-day clinical outcome
Death, 𝑛 (%)	2 (13.3)	0
Cardiac death, 𝑛 (%)	2 (13.3)	0
LVEF (%), mean ± SD	49.67 ± 10.4	52.73 ± 10.1
Six-month cumulative clinical outcome
Death, 𝑛 (%)	4 (26.6)	2 (18.2)
Cardiac death, 𝑛 (%)	4 (26.6)	1 (9.1)
LVEF (%), mean ± SD	56.22 ± 4.12	60.23 ± 3.45

SD: standard deviation; CVVH: continuous venovenous hemofiltration; LVEF: left ventricle ejection fraction.